These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 1941824)
61. [Autoimmunity and autoinflammation in pathogenesis of immunoinflammatory diseases]. Shilkina NP; Masina IV; Dryazhenkova IV; Vinogradov AA; Yunonin IE Ter Arkh; 2020 Dec; 92(12):120-125. PubMed ID: 33720583 [TBL] [Abstract][Full Text] [Related]
62. Circulating intercellular adhesion molecules-1 and autoantibodies including anti-endothelial cell, anti-cardiolipin, and anti-neutrophil cytoplasma antibodies in patients with vasculitis. Wang CR; Liu MF; Tsai RT; Chuang CY; Chen CY Clin Rheumatol; 1993 Sep; 12(3):375-80. PubMed ID: 8258240 [TBL] [Abstract][Full Text] [Related]
63. [Antiphospholipid antibody syndrome as the cause of clinical rapidly progressing vasculopathy]. Henning BF; Büchner N; Kirchner J; Gillessen A Dtsch Med Wochenschr; 2000 May; 125(19):589-93. PubMed ID: 11320717 [TBL] [Abstract][Full Text] [Related]
64. Antineutrophil cytoplasmic antibody in uveitis and scleritis. Mills RA; Weeramanthri TS; Hollingsworth PN; Cooper RL Aust N Z J Ophthalmol; 1991 Feb; 19(1):71-3. PubMed ID: 2039628 [TBL] [Abstract][Full Text] [Related]
65. Evolving concepts about the role of antineutrophil cytoplasm autoantibodies in systemic vasculitides. Bajema IM; Hagen EC Curr Opin Rheumatol; 1999 Jan; 11(1):34-40. PubMed ID: 9894628 [TBL] [Abstract][Full Text] [Related]
66. Anticardiolipin antibodies in systemic sclerosis: immunological and clinical associations. Malia RG; Greaves M; Rowlands LM; Lawrence AC; Hume A; Rowell NR; Moult J; Holt CM; Lindsey N; Hughes P Clin Exp Immunol; 1988 Sep; 73(3):456-60. PubMed ID: 2974767 [TBL] [Abstract][Full Text] [Related]
67. Systemic vasculitis positive for circulating anti-neutrophil cytoplasmic antibodies and with predominantly neurological presentation. Stumvoll M; Schnauder G; Overkamp D; Buettner UW; Grodd W; Eggstein M Clin Investig; 1993 Aug; 71(8):613-5. PubMed ID: 8219655 [TBL] [Abstract][Full Text] [Related]
68. Correlations between plasma levels of a fibronectin isoform subpopulation and C-reactive protein in patients with systemic inflammatory disease. Peters JH; Greasby T; Lane N; Woolf A Biomarkers; 2009 Jun; 14(4):250-7. PubMed ID: 19489687 [TBL] [Abstract][Full Text] [Related]
69. Vascular biology and vasculitis. Savage CO APMIS Suppl; 2009 Jun; (127):37-40. PubMed ID: 19515138 [TBL] [Abstract][Full Text] [Related]
70. MPO-ANCA-associated pseudovasculitis in cardiac myxoma. Nishio Y; Ito Y; Iguchi Y; Sato H Eur J Neurol; 2005 Aug; 12(8):619-20. PubMed ID: 16053470 [TBL] [Abstract][Full Text] [Related]
71. Microscopic polyarteritis. Report of a case with cutaneous involvement and antimyeloperoxidase antibodies. Homas PB; David-Bajar KM; Fitzpatrick JE; West SG; Tribelhorn DR Arch Dermatol; 1992 Sep; 128(9):1223-8. PubMed ID: 1325755 [TBL] [Abstract][Full Text] [Related]
73. [Growth factors and cytokines in the pathogenesis of systemic vasculitis]. Gross WL; Csernok E; Kekow J Verh Dtsch Ges Inn Med; 1991; 97():469-77. PubMed ID: 1808930 [No Abstract] [Full Text] [Related]
74. Serological testing in small vessel vasculitis. Segelmark M Rheumatology (Oxford); 2020 May; 59(Suppl 3):iii51-iii54. PubMed ID: 32348521 [TBL] [Abstract][Full Text] [Related]
75. Antibodies and vascular involvement in inflammatory joint disease: clinical relevance. Vittecoq O; Jouen-Beades F; Tron F; Le Loët X Joint Bone Spine; 2001 Dec; 68(6):466-76. PubMed ID: 11808982 [TBL] [Abstract][Full Text] [Related]
76. Antibodies to neutrophil cytoplasmic antigen in systemic vasculitis. Venning MC; Arfeen S; Bird AG Lancet; 1987 Oct; 2(8563):850. PubMed ID: 2889043 [No Abstract] [Full Text] [Related]
77. Formalin fixation and patterns of antineutrophil cytoplasmic antibodies. Spickett GP; Broomhead V J Clin Pathol; 1995 Jan; 48(1):89-90. PubMed ID: 7706530 [TBL] [Abstract][Full Text] [Related]
78. Autoantibodies and endothelial dysfunction in well-controlled, uncomplicated insulin-dependent diabetes mellitus patients. Ciarla MV; Bocciarelli A; Di Gregorio S; Tordi A; Cotroneo P; Marra G; Ghirlanda G; Strom R Atherosclerosis; 2001 Sep; 158(1):241-6. PubMed ID: 11500197 [TBL] [Abstract][Full Text] [Related]
79. Antibodies to neutrophil cytoplasmic antigens: serologic marker for Sweet's syndrome. Kemmett D; Harrison DJ; Hunter JA J Am Acad Dermatol; 1991 Jun; 24(6 Pt 1):967-9. PubMed ID: 1869685 [TBL] [Abstract][Full Text] [Related]
80. The pathogenic role of anti-neutrophil cytoplasm autoantibodies. Meyer O Ann Med Interne (Paris); 1992; 143(7):423-5. PubMed ID: 1300859 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]